Remed Co.,Ltd. (KOSDAQ: 302550)

Market Cap	116.12B
Revenue (ttm)	23.42B
Net Income (ttm)	4.86B
Shares Out	30.64M
EPS (ttm)	158.73
PE Ratio	23.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,980
Open	3,800.00
Previous Close	3,800.00
Day's Range	3,695.00 - 3,830.00
52-Week Range	2,545.00 - 4,420.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 21, 2025

About Remed Co.,Ltd.

Remed Co.,Ltd. engages in the manufactures and supplies of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as tinnitus, insomnia, dementia, stress, anxiety, etc. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In addition, the company provides e...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2003
• Employees: 91
• Stock Exchange: KOSDAQ
• Ticker Symbol: 302550

Financial Performance

In 2023, Remed Co.,Ltd.'s revenue was 18.54 billion, a decrease of -13.23% compared to the previous year's 21.36 billion. Earnings were 797.17 million, a decrease of -80.07%.